Zhiyuan Qiu

Yangzhou University

H指数:9

被引数:289

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic factors and quality of life in non-small cell lung cancer with leptomeningeal metastasis: a dichotomous pattern based on parenchymal involvement

预后因素和生存质量在软脑膜转移的非小细胞肺癌中的二分模式：基于肺实质受累情况

Journal of Neuro-Oncology

IF3.1

2025-12-100

OAAI

Targeting the Phosphoinositide 3-Kinase/Protein Kinase B Pathway Suppresses Y-Box Binding Protein 1 Expression and Inhibits Colorectal Cancer Progression

靶向磷脂酰肌醇3-激酶/蛋白激酶B通路抑制Y盒结合蛋白1表达并抑制结直肠癌进展

WORLD JOURNAL OF ONCOLOGY

IF2.2

2025-10-010

OAAI

Evaluation of the efficacy and safety of HyperArc stereotactic radiotherapy for the treatment of lung cancer brain metastasis

评估HyperArc立体定向放射疗法治疗肺癌脑转移的疗效与安全性

Medical Oncology

IF3.5

2025-08-060

OAAI

Enhancement of poly-l-lactic acid stents through polydopamine coating: Boosting endothelialization and suppressing inflammation (vol 81, pg 525, 2023)

聚左旋乳酸支架通过聚多巴胺涂层进行增强：促进内皮化和抑制炎症（卷 81，页 525，2023）

ALEXANDRIA ENGINEERING JOURNAL

IF6.8

2025-06-010

PRE

Endogenous Hydrogen Sulphide Promotes the Ex Vivo Expansion of Haematopoietic Stem Cells by Regulating the Activation of the JAK2/STAT3 Pathway

内源性硫化氢通过调控JAK2/STAT3通路的激活促进造血干细胞的体外扩增

IMMUNOLOGY

IF5

2025-05-220

PRE

Dauricine Impedes the Tumorigenesis of Lung Adenocarcinoma by Regulating Nrf2 and Reactive Oxygen Species

Dauricine 通过调控 Nrf2 和活性氧阻止肺腺癌的致癌作用

CELLS

IF5.2

2025-05-120

USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression

CELL COMMUNICATION AND SIGNALING

IF8.9

2025-01-300

OAAI

Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2025-01-170

OAAI

Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer

CANCER BIOLOGY & THERAPY

IF4.6

2024-08-203

OAAI

Optimizing the Biocompatibility of PLLA Stent Materials: Strategy with Biomimetic Coating

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2024-06-010

OAAI

Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2023-11-073

OAAI

Enhancement of Poly-L-lactic acid stents through polydopamine coating: Boosting endothelialization and suppressing inflammation

ALEXANDRIA ENGINEERING JOURNAL

IF6.8

2023-10-013

OAAI

Expression of p53 as a biomarker in determining response to apatinib for advanced gastric cancer

FRONTIERS IN ONCOLOGY

IF3.3

2023-08-152

OAAI

Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications

FRONTIERS IN ONCOLOGY

IF3.3

2022-11-2328

OAAI

Association between long noncoding RNA rs944289 and rs7990916 polymorphisms and the risk of colorectal cancer in a Chinese population

SCIENTIFIC REPORTS

IF3.9

2022-02-153

OAAI

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation

间充质干细胞治疗单倍体相合异基因造血干细胞移植后多药耐药移植物抗宿主病的有效性和安全性

THERAPEUTIC ADVANCES IN HEMATOLOGY

IF3.1

2022-01-208

OAAI

Lack of association between miR-146a rs2910164 C/G locus and colorectal cancer: from a case-control study to a meta-analysis

BIOSCIENCE REPORTS

IF4.7

2021-01-044

OAAI

Large granular lymphocytosis during dasatinib therapy

CANCER BIOLOGY & THERAPY

IF4.6

2013-12-1836

OAAI

STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2013-10-3137

OAAI

Zhiyuan Qiu

个人简介

教育背景

工作经历

荣誉奖项

研究方向